What Happened?
South San Francisco, CA-based RAPT Therapeutics Appointed Gwen Carscadden as Chief Human Resources Officer
About the Company
RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Utilizing its proprietary discovery and development engine, the company develops highly selective small molecules that are designed to modulate the fundamental immune responses underlying these diseases. RAPT has rapidly discovered and advanced two unique drug candidates each targeting CCR4, including our lead oncology drug candidate, FLX475, now in clinical development and our lead inflammation drug candidate, RPT193, expected to enter the clinic in the second half of 2019. The company is also pursuing other discovery targets including GCN2 and HPK1 for the treatment of cancer.
About the Person
Gwen Carscadden is Chief Human Resources Officer at RAPT Therapeutics. Previously, Gwen held various senior HR leadership roles in the industry.
Info Source
News
Short Profile